Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Pyruvate Bronchodilation in Asthmatics
NCT00262652Phase 2Terminated
- Sponsor
- EmphyCorp Inc.
- Start
- Jan 2006
- Primary completion
- Sep 2006
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Sodium Pyruvate with Placebo (2 arms). Primary endpoints: Improvement of FEV1 at 15 months, FEV1% Predicted at 240 months and 1 more. Started Jan 2006; status: terminated.
02
Drugs
sodium pyruvate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00262652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262652.